Principles and practice of antimicrobial therapy of the infected joint replacement

Current Orthopaedics

Volumn 14, Issue 4, 2000, Pages 250-256

  Jones, N ^a   Berendt, A R ^b  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIMICROBIAL THERAPY; BACTERIUM IDENTIFICATION; CONFERENCE PAPER; GRAFT INFECTION; HUMAN; INFECTION RISK; PRACTICE GUIDELINE; PRIORITY JOURNAL; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; TREATMENT INDICATION;

EID: 0034460190     PISSN: 02680890     EISSN: None     Source Type: Journal    
DOI: 10.1054/cuor.2000.0121     Document Type: Conference Paper

References (26)

1. Prognosis of total hip replacement in Sweden. Follow-up of 92,675 operations performed 1978-1990
2. Perioperative factors associated with septic arthritis after arthroplasty. Prosperative multicenter study of 362 knee and 2,651 hip operations
3. Prospective evaluation of criteria for microbiological diagnosis of prosthetic-joint infection at revision arthroplasty. The OSIRIS Collaborative Study Group
4. An assessment of the histological criteria used to diagnose infection in hip revision arthroplasty tissues
5. Susceptibility of oral bacterial biofilms to antimicrobial agents
6. Alteration of cutaneous staphylococcal flora as a consequence of antimicrobial prophylaxis
7. Outpatient parenteral antimicrobial-drug therapy
8. Antimicrobial prophylaxis in total hip replacement: A systematic review
9. Antibiotic prophylaxis in orthopedic surgery
10. Treatment of infection with debridement and retention of the components following hip arthroplasty
11. Evaluation and treatment of infection at the site of a total hip or knee arthroplasty
12. Direct-exchange arthroplasty for the treatment of infection after total hip replacement. An average ten-year follow-up
13. Management of deep infection of total hip replacement
14. One-stage revision of total hip arthroplasty for deep infection. Long-term follow up
15. One stage revision of infected total hip replacement with discharging sinuses
16. Staphylococcus epidermidis: Emerging resistance and need for alternative agents
17. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-intermediate Staphylococcus aureus Working Group
18. Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections
19. Antimicrobial treatment of orthopedic implant-related infections with rifampin combinations
20. Oral rifampin plus ofloxacin for treatment of Staphylococcus-infected orthopedic implants
21. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: A randomized controlled trial. Foreign-Body Infection (FBI) Study Group
22. Prolonged suppressive antibiotic therapy for infected orthopedic prostheses
23. Antibiotic-impregnated cement and beads for orthopedic infections
24. Gentamicin release from old cement during revision hip arthroplasty
25. Safe intravenous antibiotic therapy at home: Experience of a UK based programme
26. Experience with a physician-directed, clinic-based program for outpatient parenteral antibiotic therapy in the USA